Cartesian Therapeutics (RNAC) EPS (2016 - 2026)
Cartesian Therapeutics (RNAC) EPS from Mar 31, 2016 to Mar 31, 2026. The TTM Cartesian Therapeutics (RNAC) EPS is -$5.70. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Cartesian Therapeutics (RNAC) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +333.34% |
| 3 Years TTM | +24.69% |
| 5 Years TTM | -22.75% |
| 10 Years TTM | +5.18% |
Annual EPS change of Cartesian Therapeutics (RNAC)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$1.37 | -72.60% |
| 2025 | -$5.01 | +66.73% |
| 2024 | -$3.00 | -92.62% |
| 2023 | -$40.71 | -686.34% |
| 2022 | $6.94 | -211.25% |
| 2021 | -$6.24 | -67.40% |
| 2020 | -$19.14 | -0.60% |
| 2019 | -$19.25 | +441.37% |
| 2016 | -$3.56 | -69.29% |
| 2015 | -$11.58 | N/A |
Comparison Cartesian Therapeutics (RNAC) five years EPS CAGR with competitors
Cartesian Therapeutics (RNAC) five years EPS CAGR is -22.75%.